Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00720980
Other study ID # IRB5074
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2008
Est. completion date July 2008

Study information

Verified date April 2024
Source Henry Ford Health System
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Granuloma annulare is a benign, usually self-limiting, cutaneous dermatosis, which typically presents as asymptomatic, flesh-colored or red papules, frequently arranged in an annular pattern on the distal extremities. Although localized granuloma annulare is most commonly observed, a generalized or disseminated form can occur. The etiology of granuloma annulare is unknown, however, multiple inciting factors have been proposed. The purpose of the investigators is to review the outcomes of treatment of granuloma annulare (GA) resistant to standard regimens that resolved after a 3-months treatment course of monthly rifampin, ofloxacin, and minocycline (ROM) therapy, successfully used to treat paucibacillary leprosy, a disease with clinical and histopathologic similarity to GA.


Description:

We will document the regimen treatment each patient has had and then review the following from the patient's chart to target our specific aims as outlined above. 1. What previous treatment options have been or/are currently being used? 2. How long did the patient take the treatment for? 3. Was the patient able to discontinue or become less dependent on prior treatment? 4. Was the disease process slowed by the treatment?; 5. Were there any side effects that the patient experienced with treatment?


Recruitment information / eligibility

Status Completed
Enrollment 6
Est. completion date July 2008
Est. primary completion date May 2008
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients with granuloma annulare who are resistent to the standard treatment. Exclusion Criteria: - Response to the standard treatment of granuloma annulare.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Henry Ford Medical Center Detroit Michigan

Sponsors (1)

Lead Sponsor Collaborator
Henry Ford Health System

Country where clinical trial is conducted

United States, 

References & Publications (1)

Duarte AF, Mota A, Pereira MA, Baudrier T, Azevedo F. Generalized granuloma annulare--response to doxycycline. J Eur Acad Dermatol Venereol. 2009 Jan;23(1):84-5. doi: 10.1111/j.1468-3083.2008.02707.x. Epub 2008 Apr 1. No abstract available. — View Citation

See also
  Status Clinical Trial Phase
Recruiting NCT05580042 - Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients With Granuloma Annulare Phase 1
Active, not recruiting NCT05650736 - Janus Kinase Inhibition in Granuloma Annulare Phase 2
Completed NCT03630198 - Pain Outcomes Following Intralesional Corticosteroid Injections Phase 4
Completed NCT05472636 - Evaluation of 41 Cases of Pediatric Granuloma Annulare
Terminated NCT00476697 - UVA1 Light for Scleroderma and Similar Conditions N/A
Completed NCT00129428 - Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix Phase 1/Phase 2
Completed NCT03910543 - Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare Phase 1